These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma. Tateyama H; Eimoto T; Tada T; Hattori H; Murase T; Takino H Am J Clin Pathol; 1999 Feb; 111(2):235-40. PubMed ID: 9930146 [TBL] [Abstract][Full Text] [Related]
4. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity. Dorfman DM; Shahsafaei A; Chan JK Am J Surg Pathol; 1997 Aug; 21(8):936-40. PubMed ID: 9255257 [TBL] [Abstract][Full Text] [Related]
5. CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms. Kornstein MJ; Rosai J Am J Clin Pathol; 1998 Jun; 109(6):722-6. PubMed ID: 9620029 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma. Dorfman DM; Shahsafaei A; Miyauchi A Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728 [TBL] [Abstract][Full Text] [Related]
8. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile. Kuo TT; Chan JK Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173 [TBL] [Abstract][Full Text] [Related]
9. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors. Chan JK; Tsang WY; Seneviratne S; Pau MY Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670 [TBL] [Abstract][Full Text] [Related]
10. Intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation; comparison with thymic lymphoepithelioma-like carcinoma and a possibility of development from a multipotential stem cell. Hirokawa M; Miyauchi A; Minato H; Yokoyama S; Kuma S; Kojima M APMIS; 2013 Jun; 121(6):523-30. PubMed ID: 23176314 [TBL] [Abstract][Full Text] [Related]
11. Intrathyroid epithelial thymoma (ITET) and carcinoma showing thymus-like differentiation (CASTLE): CD5-positive neoplasms mimicking squamous cell carcinoma of the thyroid. Kakudo K; Bai Y; Ozaki T; Homma K; Ito Y; Miyauchi A Histol Histopathol; 2013 May; 28(5):543-56. PubMed ID: 23233417 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms. Pomplun S; Wotherspoon AC; Shah G; Goldstraw P; Ladas G; Nicholson AG Histopathology; 2002 Feb; 40(2):152-8. PubMed ID: 11952859 [TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma. Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic significance of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation: a collaborative study with Member Institutes of The Japanese Society of Thyroid Surgery. Ito Y; Miyauchi A; Nakamura Y; Miya A; Kobayashi K; Kakudo K Am J Clin Pathol; 2007 Feb; 127(2):230-6. PubMed ID: 17210519 [TBL] [Abstract][Full Text] [Related]
15. Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: a large scale study of 1465 non-small cell lung cancer cases. Kriegsmann M; Muley T; Harms A; Tavernar L; Goldmann T; Dienemann H; Herpel E; Warth A Diagn Pathol; 2015 Dec; 10():210. PubMed ID: 26643918 [TBL] [Abstract][Full Text] [Related]
16. Two malignant tumours in the anterior mediastinum positive for CD5. Steger CM; Morresi-Hauf A; Krugmann J; Schirmacher P; Rieker RJ; Mechtersheimer G BMJ Case Rep; 2010 Jul; 2010():. PubMed ID: 22752456 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas. Su XY; Wang WY; Li JN; Liao DY; Wu WL; Li GD Int J Clin Exp Pathol; 2015; 8(5):5354-62. PubMed ID: 26191237 [TBL] [Abstract][Full Text] [Related]